← FDA Drug Approvals (Drugs@FDA)

COMBIVENT RESPIMAT

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2011-10-07

Drug application

FDA Application #
NDA021747
Application type
New Drug Application
Brand name
COMBIVENT RESPIMAT
Generic name
IPRATROPIUM BROMIDE AND ALBUTEROL
Active ingredients
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
Dosage form
SPRAY, METERED
Route
INHALATION
Marketing status
Prescription
Sponsor
BOEHRINGER INGELHEIM
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
First approval
2011-10-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown